Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -.--% |
2016 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
2015 | Urologix Conducting A Strategic Review | CI |
Business Summary
Number of employees: 61
Sales per Business
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
Medical Products
100.0
%
| 17 | 100.0 % | 14 | 100.0 % | -14.20% |
Sales per region
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 17 | 100.0 % | 14 | 100.0 % | -14.20% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 29/91/29 |
Scott Madson
DFI | Director of Finance/CFO | 63 | 01/15/01 |
Lisa Ackermann
SAM | Sales & Marketing | 51 | 16/11/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 29/91/29 |
Sidney Emery
BRD | Director/Board Member | 74 | 01/05/01 |
Director/Board Member | 57 | 06/10/06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,817,726 | 21,817,726 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Urologix, Inc.
14405 21st Avenue North
55447-4699, Minneapolis
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.13K | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- ULGX Stock
- Company Urologix, Inc.